You might like
Today, during the annual "JPM Week" in San Francisco, CEO, David “DSO” Suendermann-Oeft, PhD participated in a panel discussion "What is TechBio and What Impact Will It Have on Therapeutic Development?"
Curious about what it takes to build a startup at the intersection of AI and medicine? Our visionary CEO, David “DSO” Suendermann-Oeft, PhD, shares his rich tapestry of roles as researcher, professor, founder, scientist, and musician... youtube.com/watch?v=i9Fo9W…
youtube.com
YouTube
David Suendermann-Oeft: Rockstar to Researcher to Entrepreneur |...
This week, our Chief Operating Officer, Lakshmi Arbatti, and Data Scientist, Abhishek Hosamath, presented their work at the Parkinson Study Group Annual Meeting in Tennessee. #pd #Parkinsons #ClinicalTrials modality.ai/news#h.6ib2i4f…
Modality Presents at Parkinson Study Group Annual Meeting: This week, our COO, Lakshmi Arbatti, and Data Scientist, Abhishek Hosamath, are presenting their work at the Parkinson Study Group Annual Meeting in Tennessee. parkinson-study-group.org/psg-2024-annua…
Modality’s CEO David "DSO" Suendermann-Oeft and Senior Research Scientist Hardik Kothare to present our work on "Multimodal Speech Biomarkers for Remote Monitoring of ALS Disease Progression" at the 7th Annual ALS Research Symposium. alsoneresearchsymposium.org
*Five New ALS Publication Acceptances* At Modality.AI, ALS remains at the very heart of our mission, so we're pleased to share that our research has recently been recognized with five new presentations at three seminal ALS conferences. modality.ai/news#h.6ib2i4f…
Attending the International Congress of Parkinson's Disease and Movement Disorders®? We invite you to connect with Modality's Head of Science Sales, Meredith Bartlett. linkedin.com/in/meredithbar…
You're invited to our next webinar, Digital Biomarkers in CNS Trials - on Friday, September 27 at 10 AM PT. modality.ai/news#h.o2btb3p…
New Publication: Multimodal Technologies for Remote Assessment of Neurological and Mental Health. The article reviews the advantages of using multimodal technologies for remote neurological and mental health assessment. #ClinicalTrials modality.ai/news#h.o2btb3p…
How can we capture a fuller picture of patient experiences in clinical trials? Find out now through this recording of a recent Modality webinar in which we discuss the Patient Report of Problems. youtu.be/D8xSlNSM1r0?si…
youtube.com
YouTube
Making Patients Heard in Clinical Research - a Modality.AI Webinar
Join us for our upcoming webinar - linkedin.com/feed/update/ur…
Modality will present four papers at the premier speech conference Interspeech 2024, taking place in Greece September 1–5. modality.ai/news#h.s54e02z…
Our CEO, David Suendermann-Oeft, will attend the Digital Biomarkers in Clinical Trials Summit on June 26, 2024, at Roche Headquarters in Basel. Be sure to connect if you’re attending. digitalbiomarkers.panagorapharma.com
Modality CEO David "DSO" Suendermann-Oeft interviewed by BioNews. bio.news/health/modalit…
Will you be at #BIO in San Diego? Let's meet! Our CEO, David Suendermann-Oeft (DSO) is sharing an update on Modality.AI on Wednesday, June 5th at 2.45pm in Presentation Room 4. DSO will also present on Thursday afternoon in the NIH booth. #BIOInternationalConvention
United States Trends
- 1. Epstein 573K posts
- 2. Steam Machine 23.4K posts
- 3. Virginia Giuffre 28.7K posts
- 4. Valve 17.3K posts
- 5. Boebert 12.6K posts
- 6. #BLACKROCK_NXXT N/A
- 7. Rosalina 57.7K posts
- 8. #NASDAQ_NXXT N/A
- 9. Brie Larson 20.8K posts
- 10. AJ Brown 7,949 posts
- 11. H-1B 88K posts
- 12. #NASDAQ_MYNZ 1,150 posts
- 13. GabeCube 1,258 posts
- 14. Bowser 34.4K posts
- 15. The Devil Wears Prada 2 41.5K posts
- 16. Mel Tucker N/A
- 17. Anthony Joshua N/A
- 18. Clinton 104K posts
- 19. Jordan Humphrey N/A
- 20. Mace 22.3K posts
Something went wrong.
Something went wrong.